Seeing a need to grow with acquisitions, Danish pharmaceuticals company H. Lundbeck also needed a solid funding strategy. On stage at the Treasury 360° Copenhagen conference, senior treasury director Markus Kede shared how Denmark’s largest pharma merger was enabled financially.
